Ansar Jawaid | Founder and Chief Executive Officer
Precision Medicines

Ansar Jawaid, Founder and Chief Executive Officer, Precision Medicines

Ansar is the CEO of Precision Medicines Ltd, a cancer biotech developing personalised medicines, and Director of Core Precision Ltd, a consultancy working with biotech and large pharma on developing and commercialising precision medicines. Ansar’s expertise in precision medicine development, approval and commercialisation has enabled him to initiate and lead global projects in a wide range of therapeutic areas across R&D and Commercial for both large Pharma and Biotech companies. Ansar has over 15 years experience working in this field, having supported the development, approval and commercialisation at senior leadership level of 8 medicines including cancer precision medicines Lynparza and Iressa at AstraZeneca. Ansar received a BSc in Genetics from King's College London and undertook his PhD training in Statistical Genetics at the Institute of Psychiatry at King's College London and the University of Oxford.

Appearances:



Precision 2018 Day 2 @ 15:30

Implementing precision medicines: what are the challenges?

  • Sharing of case-studies/examples on challenges and solutions in precision medicine development through to integration in treatment pathways, including;
  • Biomarker discovery
  • Clinical trial design and delivery
  • Drug-diagnostic co-development
  • Precision Medicine launch and delivery to the patient

back to speakers